Evidence map›Paper›PMID 36927848›Full record

Observational studyRMD open2023

Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment.

Uta Kiltz, Kirsten Hoeper, Ludwig Hammel, Sebastian Lieb, Andreas Hähle, Dirk Meyer-Olson

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in RMD open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Uta KiltzRuhr-Universität Bochum, Bochum, Germany uta.kiltz@elisabethgruppe.de.ORCID 0000-0001-5668-4497
Kirsten HoeperRheumatologie and Immunologie, Regionales Kooperatives Rheumazentrum Niedersachsen eV, Hannover, Germany.ORCID 0000-0002-4327-9836
Ludwig HammelDeutsche Vereinigung Morbus Bechterew e.V, Schweinfurt, Germany.
Sebastian LiebNovartis Pharma GmbH, Nurnberg, Germany.
Andreas HähleNovartis Pharma GmbH, Nurnberg, Germany.
Dirk Meyer-OlsonKlinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Hannover, Germany.ORCID 0000-0001-8000-6960

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAxial spondyloarthritis (axSpA) is a chronic inflammatory disease that typically affects people in their second and third decades of life, which are important years for establishing a professional career. We aim to study outcomes of work participation (WP) and their associations with demographic and clinical confounders, in addition to prevalence of negative workplace experiences in axSpA.

methodsIn total, 770 patients with axSpA participated in the multicentre, observational ATTENTUS-axSpA survey in Germany. Demographic information, clinical parameters and patient-related outcomes (including disease activity and function) with a focus on WP were prospectively recorded.

resultsA high prevalence of negative workplace experiences was reported among the 770 patients analysed. Overall, 23.4% of patients were not employed and 6.5% received disability pensions. Current work cessation was prevalent in 120 patients, and 28 of those were out of work for 10 years or longer. Of the 590 currently employed patients, 31.9% reported absenteeism and 35.9% reported presenteeism for >1 month within the past year. Multivariate logistic regression identified low disease activity (Bath Ankylosing Spondylitis Disease Activity Index), better physical function (Bath Ankylosing Spondylitis Functional Index) and better global functioning (Assessment of SpondylAarthritis International Society-Health Index) as the main predictors for unimpaired WP (n=242). Importantly, biological treatment, disease duration, age, sex, education level and body mass index were not reliable predictors. DISCUSSION: Despite improvements in pharmacological treatment options, we still observed substantially impaired WP in patients with axSpA. These data emphasise the high unmet need for targeted strategies to provide improved medical and social care.

Indexed as

Spondylitis, AnkylosingGermanyHumansPrevalenceSurveys and QuestionnairesWorkplaceImmune System DiseasesPatient Reported Outcome MeasuresSpondylitis, Ankylosing

Identifiers

PMID36927848
PMCPMC10030742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.